Please use this identifier to cite or link to this item:
https://mnclhd.intersearch.com.au/mnclhdjspui/handle/123456789/387Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Sarathy, K. | - |
| dc.contributor.author | Alexopoulos, C. | - |
| dc.date.accessioned | 2025-01-08T03:33:19Z | - |
| dc.date.available | 2025-01-08T03:33:19Z | - |
| dc.date.issued | 2017-06 | - |
| dc.identifier.citation | Journal of the Royal College of Physicians of Edinburgh. 2017 Jun;47(2):146-147. doi: 10.4997/JRCPE.2017.209. | en |
| dc.identifier.uri | https://mnclhd.intersearch.com.au/mnclhdjspui/handle/123456789/387 | - |
| dc.description.abstract | Clozapine-induced myopericarditis is a well-described adverse drug reaction. Clozapine is also the most efficacious agent in refractory schizophrenia. We report a case of a patient who was successfully re-trialled on clozapine two years after developing myopericarditis, after which multiple lines of alternative treatment failed. We propose a protocol for safely attempting a re-trial of clozapine in such cases. | en |
| dc.language.iso | en | en |
| dc.subject | Clozapine | en |
| dc.subject | Schizophrenia | en |
| dc.subject | Schizophrenia, Treatment-Resistant | en |
| dc.subject | Drug-Related Side Effects and Adverse Reactions | en |
| dc.subject | Myocarditis | en |
| dc.title | A successful re-trial after clozapine myopericarditis | en |
| dc.type | Article | en |
| dc.contributor.mnclhdauthor | Sarathy, Kiran | - |
| dc.contributor.mnclhdauthor | Alexopoulos, Chris | - |
| Appears in Collections: | Mental Health | |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.